PanTher Advances PTM-101 Into Expansion Phase for Non-Metastatic Pancreatic Cancer
AUSTIN, Texas | May 30, 2026 PanTher Therapeutics announced the completion of the dose-escalation portion of its Phase 1b...
Phase 1b trial
Advertisement
TRexBio Reports New TRB-061 Data for Atopic Dermatitis
SOUTH SAN FRANCISCO, Calif., May 7, 2026 TRexBio announced new late-breaking translational and preclinical data supporting TNFR2 agonism as...
Totus Medicines Reports Strong Phase 1b Clinical Results for TOS-358 in HR+/HER2- Breast Cancer
EMERYVILLE, Calif., May 6, 2026 Totus Medicines announced encouraging interim Phase 1b clinical data for its investigational therapy TOS-358...
Cocrystal Pharma Advances CDI-988 for Norovirus Care
BOTHELL, Wash., April 30, 2026 Cocrystal Pharma, Inc., a clinical-stage biotechnology company focused on antiviral therapeutics, has presented new...
TRexBio Advances TRB-061 Phase 1b Trial for Atopic Dermatitis
SOUTH SAN FRANCISCO, April 29, 2026 TRexBio, Inc. has announced that the first patient has been dosed in the...
Advertisements
PureTech Reports Positive LYT-200 Phase 1b Trial Data
BOSTON, USA, April 22, 2026 PureTech Health plc has announced positive topline results from its Phase 1b clinical trial...
Phio Pharmaceuticals Reports Positive PH-762 Skin Cancer Data
KING OF PRUSSIA, PENNSYLVANIA, March 23, 2026 Phio Pharmaceuticals Corp. has announced the presentation of positive clinical study results...
J&J Pasritamig Combo Shows Strong mCRPC Activity
RARITAN, N.J., February 26, 2026 Johnson & Johnson (NYSE: JNJ) announced preliminary Phase 1b clinical results demonstrating promising antitumor...
VRON-0200 Shows Durable Immunity in HBV Trial
PHILADELPHIA, Feb. 22, 2026 — Virion Therapeutics reported new Phase 1b clinical data at the 33rd Conference on Retroviruses...
Apogee Shows Durable Phase 1b Asthma Data for IL-13 Biologic
SAN FRANCISCO & BOSTON | January 6, 2026 — Apogee Therapeutics has reported positive interim results from a Phase...
Advertisement
